Dr. Holden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- Thomas Holden, MD is an oncology specialist based in Palo Alto, CA with a subspecialty focus on gastrointestinal cancer. Dr. Holden completed medical school at the University of Oklahoma College of Medicine in 2015. His residency in Internal Medicine was at Sidney Kimmel Medical College at Thomas Jefferson University/TJUH, followed by a fellowship in Hematology and Medical Oncology at Temple University Hospital. Dr. Holden holds an undergraduate degree in Biology from Baylor University. His experience lies primarily in gastrointestinal oncology, and he has authored several publications in this field. Dr. Holden has been recognized for his academic achievements, receiving the Phi Kappa Phi honor in 2014.
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2016 - 2019
University of Oklahoma College of MedicineClass of 2015
Baylor UniversityBA, Biology, 2006 - 2010
Certifications & Licensure
CA State Medical License 2022 - 2026
PA State Medical License 2015 - 2022
OH State Medical License 2015 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Phi Kappa Phi The Honor Society of Phi Kappa Phi, 2014
Publications & Presentations
PubMed
- Nonoperative Management for Rectal Cancer.Erqi L Pollom, Vipul R Sheth, Aaron J Dawes, Thomas Holden
Cancer Journal. 2024-07-23 - 1 citationsExpanding Germline Testing to All Patients With Esophagogastric Cancers-Easy to Do, Harder to Justify.Thomas L Holden, Catherine Neumann, Michael J. Hall
JAMA Network Open. 2021-07-01 - 10 citationsFeasibility of Fitness Tracker Usage to Assess Activity Level and Toxicities in Patients With Colorectal Cancer.William H. Ward, Caitlin R. Meeker, Elizabeth Handorf, Maureen V. Hill, Margret B. Einarson
JCO Clinical Cancer Informatics. 2021-01-25
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
